Loading
Thoracic surgeon-scientist and hospital Vice President who led the ADJUVANT/CTONG1104 trial establishing adjuvant EGFR-TKI therapy in resected lung cancer.
Wen-Zhao Zhong is Vice President of Guangdong Provincial People's Hospital and a thoracic surgical oncologist at the Guangdong Lung Cancer Institute. He was first author of the ADJUVANT/CTONG1104 phase 3 trial, which compared adjuvant gefitinib with chemotherapy in resected EGFR-mutant non-small-cell lung cancer, and has published extensively on perioperative targeted therapy through the Chinese Thoracic Oncology Group.
Shares Guangdong Provincial People's Hospital and the tag leadership.
Shares Non-small-cell lung cancer and the tags clinician-scientist, leadership, lung cancer.
Shares Non-small-cell lung cancer and the tags clinician-scientist, leadership, lung cancer.
Shares Non-small-cell lung cancer and the tags clinician-scientist, leadership, lung cancer.
Shares Non-small-cell lung cancer and the tags clinician-scientist, leadership, lung cancer.
Shares Non-small-cell lung cancer and the tags clinician-scientist, leadership, lung cancer.
Shares Non-small-cell lung cancer and the tags clinician-scientist, leadership, lung cancer.
Shares Non-small-cell lung cancer and the tags clinician-scientist, leadership, lung cancer.